245 related articles for article (PubMed ID: 18336345)
1. Strategies for in vivo siRNA delivery in cancer.
Sanguino A; Lopez-Berestein G; Sood AK
Mini Rev Med Chem; 2008 Mar; 8(3):248-55. PubMed ID: 18336345
[TBL] [Abstract][Full Text] [Related]
2. Advances in siRNA delivery in cancer therapy.
Singh A; Trivedi P; Jain NK
Artif Cells Nanomed Biotechnol; 2018 Mar; 46(2):274-283. PubMed ID: 28423924
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic siRNA: principles, challenges, and strategies.
Gavrilov K; Saltzman WM
Yale J Biol Med; 2012 Jun; 85(2):187-200. PubMed ID: 22737048
[TBL] [Abstract][Full Text] [Related]
4. Combinatorial siRNA Polyplexes for Receptor Targeting.
Lee DJ; Wagner E
Methods Mol Biol; 2019; 1974():83-98. PubMed ID: 31098997
[TBL] [Abstract][Full Text] [Related]
5. Tumor-targeted delivery of siRNA by non-viral vector: safe and effective cancer therapy.
Chen Y; Huang L
Expert Opin Drug Deliv; 2008 Dec; 5(12):1301-11. PubMed ID: 19040393
[TBL] [Abstract][Full Text] [Related]
6. Targeted delivery systems of small interfering RNA by systemic administration.
Kawakami S; Hashida M
Drug Metab Pharmacokinet; 2007 Jun; 22(3):142-51. PubMed ID: 17603214
[TBL] [Abstract][Full Text] [Related]
7. Functional nanostructures for effective delivery of small interfering RNA therapeutics.
Hong CA; Nam YS
Theranostics; 2014; 4(12):1211-32. PubMed ID: 25285170
[TBL] [Abstract][Full Text] [Related]
8. Biomaterials in siRNA Delivery: A Comprehensive Review.
Ho W; Zhang XQ; Xu X
Adv Healthc Mater; 2016 Nov; 5(21):2715-2731. PubMed ID: 27700013
[TBL] [Abstract][Full Text] [Related]
9. Targeted Liposomes for siRNA Delivery to Cancer.
Eloy JO; Petrilli R; Raspantini GL; Lee RJ
Curr Pharm Des; 2018; 24(23):2664-2672. PubMed ID: 30084323
[TBL] [Abstract][Full Text] [Related]
10. SiRNA delivery: challenges and role of carrier systems.
Shegokar R; Al Shaal L; Mishra PR
Pharmazie; 2011 May; 66(5):313-8. PubMed ID: 21699063
[TBL] [Abstract][Full Text] [Related]
11. Recent progress in development of siRNA delivery vehicles for cancer therapy.
Kim HJ; Kim A; Miyata K; Kataoka K
Adv Drug Deliv Rev; 2016 Sep; 104():61-77. PubMed ID: 27352638
[TBL] [Abstract][Full Text] [Related]
12. Delivery strategies for siRNA-mediated gene silencing.
Gilmore IR; Fox SP; Hollins AJ; Akhtar S
Curr Drug Deliv; 2006 Apr; 3(2):147-5. PubMed ID: 16611001
[TBL] [Abstract][Full Text] [Related]
13. [Types of non-viral delivery systems of small interfering RNA].
Glebova KV; Marakhonov AV; Baranova AV; Skoblov MIu
Mol Biol (Mosk); 2012; 46(3):387-401. PubMed ID: 22888629
[TBL] [Abstract][Full Text] [Related]
14. A review of the current status of siRNA nanomedicines in the treatment of cancer.
Resnier P; Montier T; Mathieu V; Benoit JP; Passirani C
Biomaterials; 2013 Sep; 34(27):6429-43. PubMed ID: 23727262
[TBL] [Abstract][Full Text] [Related]
15. Efficient siRNA delivery with non-viral polymeric vehicles.
Kim WJ; Kim SW
Pharm Res; 2009 Mar; 26(3):657-66. PubMed ID: 19015957
[TBL] [Abstract][Full Text] [Related]
16. Strategies for in vivo delivery of siRNAs: recent progress.
Higuchi Y; Kawakami S; Hashida M
BioDrugs; 2010 Jun; 24(3):195-205. PubMed ID: 20462284
[TBL] [Abstract][Full Text] [Related]
17. Nanoparticles for siRNA-Based Gene Silencing in Tumor Therapy.
Babu A; Muralidharan R; Amreddy N; Mehta M; Munshi A; Ramesh R
IEEE Trans Nanobioscience; 2016 Dec; 15(8):849-863. PubMed ID: 28092499
[TBL] [Abstract][Full Text] [Related]
18. Targeted delivery of siRNA by nonviral vectors: lessons learned from recent advances.
Li SD; Huang L
Curr Opin Investig Drugs; 2008 Dec; 9(12):1317-23. PubMed ID: 19037838
[TBL] [Abstract][Full Text] [Related]
19. siRNA delivery by a transferrin-associated lipid-based vector: a non-viral strategy to mediate gene silencing.
Cardoso AL; Simões S; de Almeida LP; Pelisek J; Culmsee C; Wagner E; Pedroso de Lima MC
J Gene Med; 2007 Mar; 9(3):170-83. PubMed ID: 17351968
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic targeting in the silent era: advances in non-viral siRNA delivery.
Guo J; Fisher KA; Darcy R; Cryan JF; O'Driscoll C
Mol Biosyst; 2010 Jul; 6(7):1143-61. PubMed ID: 20431817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
